Maryland Hospital Malpractice Lawsuit Results in $1.3M Verdict

|

Two teen boys who lost their mother during surgery at a Baltimore City hospital due to medical negligence, were awarded $1.3 million last week by a Maryland jury.

The jury found that Union Memorial Hospital was liable for the death of Erica Goodman, who was 34 years old when she died in November 2005. According to a report in the Maryland Daily Record, Goodman went into cardiac arrest during a medical procedure to insert a blood clot filter, which the family claimed occurred when the vein and aorta were pierced.

In their hospital malpractice lawsuit, the family alleged that the surgery was unnecessary for her condition, which they argued could have been treated with medication. The jury found that Dr. Mojtaba Gashti, who was not a named defendant in the lawsuit, failed to adhere to the accepted standards of medical care.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Following a one week trial, the Baltimore City Circuit Court jury awarded Goodmanโ€™s two sons, ages 14 and 11, $467,000 for loss of the household services of their mother and $400,000 each for their loss and suffering. Goodmanโ€™s estate was also awarded $100,00 for her conscious pain and suffering before death.

As a result of the damages cap in Maryland malpractice lawsuits, the non-economic damages portion of the award is expected to be reduced to $812,500, bringing the total judgment to $1,279,500.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโ€™s lymphoma.
Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.
Growing reports of GalaFLEX breast mesh complications have raised concerns about women who required explant surgery, revision procedures or implant removal after the synthetic mesh was used during breast augmentation, breast lift, implant revision or reconstruction surgery.